Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-13 · accession 0001048477-24-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-17 | 2024-04-30 | BMRN | FUCHS HENRY J | Pres, Worldwide R, D | A - Grant | $68.65 | +300 | 197.2K | +0.2% | +$20.6K | |
| 2024-09-17 | 2024-09-13 | BMRN | FUCHS HENRY J | Pres, Worldwide R, D | F - Tax | $84.90 | -12.1K | 185.1K | -6% | -$1.03M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-30 | A | A | 300 | $68.65 | 197,172 | D | — | — | (F1) Represents the shares acquired by the reporting person on April 30, 2024, pursuant to the issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2024-09-13 | F | D | 12,098 | $84.90 | 185,074 | D | — | — |